ELIZABETH FALICON: Open Payments
NPI 1104246727 · NEW LONDON, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 9 payments from 3 companies in 2025. Trend: 2023 $62 · 2024 $112 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $94 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Novo Nordisk Inc | 3 | $53 |
Products named: GARDASIL 9, QULIPTA, UBRELVY, Ozempic, Wegovy.
Industry payments across NH — which companies pay providers there.
